Prediction of Potential Drug Activity and Therapeutic Targets of a Natural Compound Niga-ichigoside F1 Based on Network Pharmacology and Molecular Docking

Objective:To study the drug activity and therapeutic targets of Niga-ichigoside F1 predicted based on network pharmacology and molecular docking.Methods:Download the 2D and 3D structures of Niga-ichigoside F1 from the PubChem database for target prediction and molecular docking,respectively.Target information was predicted by PharmMapper and swiss ADME databases,target gene names were extracted and rechecked by Uniprot database,and disease information corresponding to target was queried by TTD database.The enrichment analysis of GO and KEGG signal pathway was conducted by Metascape database.AutoDuck Vina was used for molecular docking of Niga-ichigoside F13D structure with key proteins of related diseases and common pathways.Finally,the conformation of molecular docking was visualized by PyMOL.Results:A total of 34 targets and 69 related disease information were obtained from the database screening.The targets with high degree of acquisition of the association network between target and disease were AR,F2,VDR,PDE10A,mTOR,and NR3C2,etc..Diseases with a high degree of relief were solid tumour,breast cancer,acute myeloid leukemia,hypertension,and thrombocytopenia,etc..The items with significance in GO analysis included positive regulation of transferase activity,protein autophosphorylation,negative regulation of cGMP-mediated signaling,intracellular receptor signaling pathway,regulation of cellular response to stress,blood vessel development,reactive oxygen species metabolic process,negative regulation of immune response,regulation of transcription from RNA polymerase Ⅱ promoter in response to stress,and nucleobase-containing small molecule metabolic process,etc..The items with significance in KEGG enrichment analysis(P<0.01)included Pathways in cancer,Purine metabolism,Focal adhesion,MAPK signaling pathway,GnRH signaling pathway,AGE-RAGE signaling pathway in diabetic complications,Ras signaling pathway,Leukocyte transendothelial migration and Platelet activation,etc..Molecular docking suggested that the target of Niga-ichigoside F1 had good binding ability with related diseases and key proteins of common pathways.Conclusion:According to the results of network pharmacology and molecular docking,Niga-ichigoside F1 has rich drug activity and may act on a variety of diseases.After comprehensive analysis,we proposed for the first time the high correlation between Niga-ichigoside F1 and cancer,as well as the possible association with acute myeloid leukemia and hypertension.It has the characteristics of multi-target and multi-pathway,which is worthy of further research,development and utilization.